Pelvic Organ Prolapse-Associated Cystitis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Foxman B. Recurrent urinary tract infections: incidence and risk factors. Am J Public Health. 1990;80:331–3.
Stern JA, Hsieh YC, Schaeffer AJ. Residual urine in an elderly female population: novel implications for oral oestrogen replacement and impact on recurrent urinary infections. J Urol. 2004;171:768–70.
O’Reilly M. Recurrent urinary tract infections. In: Stanton SL, Dwyer PL, editors. Urinary tract infection in the female. London: Martin Dunitz; 2000. p. 227–36.
Bruce AW, Reid G, McGroarty JA, Taylor M, Preston C. Preliminary study on the prevention of recurrent urinary tract infections in adult women using intravaginal lactobacilli. Int Urogynecol J. 1992;3:22–5.
Franco AVM. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol. 2005;19:861–73.
Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K. Risk factors for recurrent UTI in young women. Clin Infect Dis. 1997;25:440.
Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent UTI in young women. J Infect Dis. 2000;182:1177–82.
Foxman B, Manning SD, Tallman P, et al. Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol. 2000;156:1133–40.
Fihn SD, Boyko EJ, Normand EH, et al. Association between the use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol. 1996;144:512–20.
Hopkins WJ, Uehling DT, Wargowski DS. Evaluation of a familial disposition to recurrent urinary tract infections in women. Am J Med Genet. 1999;83:422–4.
Hooton TM, Stapleton AE, Roberts PL, et al. Perineal anatomy and urine voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis. 1999;29:1600–1.
Fowler JE, Latta R, Stamey TA. Studies of introital colonization in women with recurrent urinary tract infections: VIII. The role of bacterial interference. J Urol. 1975;113:214–7.
Stapleton A, Nudelman E, Clausen H, Hakomori S, Stamm WE. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest. 1992;90:965–72.
Raz R, Stamm WE. A controlled trial of intravaginal oestriol in postmenopausal women with recurrent urinary tract infections. N Eng J Med. 1993;329:753–6.
Raz R, Gennesin Y, Wasser J. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152–6.
Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501–6.
Hendrix SL, Clark A, Nygaard I, et al. Pelvic organ prolapse in the women’s health initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186:1160–6.
Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979–1997. Am J Obstet Gynecol. 2003;188:108–15.
Morris R, Mock S, Dmochowski R. The case for robotics in pelvic prolapse surgery. Curr Bladder Dysfunct Rep. 2014;9:1–5. This review provides a good summary of the current techniques for treating prolapse.
Herschorn S. Female pelvic floor anatomy: the pelvic floor, supporting structures, and pelvic organs. Rev Urol. 2004;6(suppl5):S2–10.
Ashton-Miller JA, DeLancey JO. Functional anatomy of the female pelvic floor. Ann N Y Acad Sci. 2007;1101:266–96.
Brubaker L, Bump RC, Fynes M. Surgery for pelvic organ prolapse. In: Abrams P, Cordozo L, Koury S, Wein A, editors. Third international consultation on incontinence. 1st ed. Paris: Health Publication; 2005.
Linder BJ, Elliott DS. Robotic sacrocolpopexy: how does it compare with other prolapse repair techniques? Curr Urol Rep. 2013;14(3):235–9. This review addresses operative techniques, success rates, costs and complications among the various approached to sacrocolpopexy.
Sobel JD, Kaye D. Urinary tract infections. In: Mandell Gl, Bennett JC, Dolin R, eds. Mandell, Douglas, and Bennett’s: principles and practice of infectious disease. 7th ed. Philadelphia, PA: Elsevier; 2010:957.
Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. Am J Med. 2002;113(suppl 1A):35S–44.
Monane M, Gurwitz JH, Lipsitz LA, Glynn RJ, Choodnovskiy I, Avorn J. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc. 1995;43:618–22.
Kaye D, Boscia JA, Abrutyn E, Levison ME. Asymptomatic bacteriuria in the elderly. Trans Am Clin Climatol Assoc. 1989;100:155–62.
Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA. 2014;311:844–54. This excellent review gives a clinical approach to the diagnosis and management of UTI in the elderly female.
Matthews SJ, Lancaster JW. Urinary tract infections in the elderly population. Am J Geriatr Pharmacother. 2011;9:286–309.
Epp A, Larochelle A, Lovatsis D, Society of Obstetricians and Gynaecologists of Canada, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can. 2010;32:1082–101.
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40:643–54.
Mazzulli T. Diagnosis and management of simple and complicated urinary tract infections (UTIs). Can J Urol. 2012;19(suppl1):42–8.
Haylen B, Lee J, Husselbee S, Law M, Zhou J. Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction. Int Urogynecol J. 2009;20:837–42.
O’Grady F, Cattell WR. Kinetics of urinary tract infections II. The bladder Br J Urol. 1996;38:156–62.
Haylen BT, Lee J, Logan V, Husselbee S, Zhou J, Law M. Immediate postvoid residual volumes in women with symptoms of pelvic floor dysfunction. Obstet Gynecol. 2008;111:1305–12.
Haylen BT, Law MG, Frazer M, Schulz S. Urine flow rates and residual urine volumes in urogynaecology patients. Int Urogynecol J. 1999;10:378–83.
Haylen BT, Verity L, Schulz S, Zhou J, Krishnan S, Sutherst JR. Has the true incidence of voiding difficulty in women been underestimated? Int Urogynecol J. 2007;18:53–6.
Novi JM, Jeronis S, Morgan MA, Arya LA. Sexual function in women with pelvic organ prolapse compared to women without pelvic organ prolapse. J Urol. 2005;173:1669–72.
Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;356:2143–55.
FitzGerald MP, Richter HE, Bradley CS, et al. Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J. 2008;19:1603–9.
Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 1998;25:723–46.
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501–6.
Anger JT, Litwin MS, Wang Q, Pashos CL, Rodriguez LV. Complications of sling surgery among female medicare beneficiaries. Obstet Gynecol. 2007;109:707–14.
Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J. 2010;21:955–61. This interesting case-control study examination risk factors for UTI in women undergoing POP or SUI surgery.
Chai TC, Albo ME, Richter HE, Norton P, Dandreo KJ, et al. Analysis of adverse events from the stress incontinence surgical treatment efficacy trial (SISTEr). J Pelvic Med Surg. 2007;13:259.
Kringel U, Reimer T, Tomczak S, Green S, Kundt G, Gerber B. Postoperative infections due to bladder catheters after anterior colporrhaphy: a prospective, randomized, three-arm study. Int Urogynecol J. 2010;21:1499–504.
Mutone N, Brizendine E, Hale D. Factors that influence voiding function after the tension-free vaginal tape procedure for stress urinary incontinence. Am J Obstet Gynecol. 2003;188:1477–83.
Cox CE, Hinman F. Experiments with induced bacteriuria, vesicle emptying and bacterial growth on the mechanism of bladder defenses to infection. J Urol. 1961;83:739.
Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin N Am. 2003;17:227–41.
Baessler K, Maher C. Pelvic organ prolapse surgery and bladder function. Int Urogynecol J. 2013;24:1843–52. This paper provides a good summary of guidance on when to treat bladder disorders at the time of prolapse surgery, including guidance on the use of prophylactic antibiotics.
DeLancey JO, Hurd WW. Size of the urogenital hiatus in the levator ani muscles in normal women and women with pelvic organ prolapse. Obstet Gynecol. 1998;91:364–8.
Saint S, Chenowith CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin N Am. 2003;17:411–32.
Wyndeale JJ. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord. 2002;40:536–41.
Galloway A, Green HT, Windsor JJ, Menon KK, Gardner BP, Krishnan KR. Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal injury. J Clin Pathol. 1986;39:851–5.
De Tayrac R, Sentilhes L. Complications of pelvic organ surgery and methods of prevention. Int Urogynecol J. 2013;24:1859–72. This useful paper summaries many of the complications associated with prolapse surgery at the current time and provides grades of recommendation for their prevention.
Rogers RG, Kammer-Doak D, Olsen A, et al. A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. Am J Obstet Gynecol. 2004;191:182–7.